Lithium and preventing chemotherapy-induced peripheral neuropathy in breast cancer patients: a placebo-controlled randomized clinical trial
ConclusionThe study showed that 300 mg lithium prescription once daily for 5 days might not effectively prevent CIPN in breast cancer patients. Evaluation of lithium effect on CIPN on different cancers in future studies is suggested.Trial registrationIranian Registry of Clinical TrialsIRCT20160813029327N10. Registration date: May 16, 2018. (Source: Trials)
Source: Trials - November 24, 2021 Category: Research Source Type: clinical trials
A Lithium-Based Medication to Improve Neurological Outcomes After Surgical Carotid Reconstruction
Conditions: Carotid Artery Diseases; Carotid Artery Stenosis Interventions: Drug: Lithium Carbonate; Drug: Placebo Sponsors: Negovsky Reanimatology Research Institute; Demikhov Municipal Clinical Hospital 68 Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 18, 2021 Category: Research Source Type: clinical trials
